Domain www.exqor.com
United States
GO-DADDY-COM-LLC
Software information
Apache
tcp/80
-
Open service 107.180.4.100:80 · www.exqor.com
2026-01-12 14:23
HTTP/1.1 200 OK Date: Mon, 12 Jan 2026 14:24:24 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade, close Last-Modified: Sun, 05 Oct 2025 15:14:40 GMT ETag: "53c15e2-250d-6406acb358d86" Accept-Ranges: bytes Content-Length: 9485 Vary: Accept-Encoding Content-Type: text/html Page title: ExQor Information <!DOCTYPE html> <html> <head> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1"> <title>ExQor Information</title> <!-- Bootstrap --> <link href="bootstrap-4.4.1.css" rel="stylesheet"> </head> <body> <p class="text-center"> <img src="images/ExQorLogo.png" width="436" height="153" alt=""/> <nav class="navbar navbar-expand-lg navbar-light bg-light"> <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation"> </button> <div class="collapse navbar-collapse" id="navbarSupportedContent"> <ul class="navbar-nav mr-auto"> <li class="nav-item active"></li> </ul> </div> </nav> <header> <div class="container"> <div class="row"> <div class="col-12"> <h2 class="text-center"><i>Regenerating the Brain</i></h2> <h2 class="text-center"><i>Restoring Cognitive Functions</i></h2> <p class="text-center"><img src="images/patientoutcomes.jpg" width="375" height="187" alt=""/></p> </div> </div> </div> </div> </header> <section> <div class="container"> <div class="row"> <div class="col-lg-12 col-md-6 col-sm-12 text-align"> <center> <h3><em>ExQor </em></h3> </center> </div> </div> </div> <div class="container "> <div class="row"> <div class="col-lg-12 col-md-6 col-sm-12 text-align"> <h4><strong> <center> Addressing A Critical Unmet Medical Need </center> </strong></h4> <p> <br> ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting Alzheimer's disease. </p> <p>Current Alzheimer's therapeutics are limited to slowing cognitive decline, but the company’s preclinical data demonstrates something fundamentally different – the ability to reverse brain damage and promote regeneration. </p> <p>An additional trial is planned for frontotemporal dementia, while exploring other conditions affecting cognitive function.</p> <center><h4><strong>Consistent Results Different Disorders</strong><strong> </strong></h4></center> </p> <p>ExQor’s preclinical studies demonstrate consistent therapeutic benefits of its regenerative medicine platform across animal models of <a href="https://www.biologicalpsychiatryjournal.com/article/S0006-3223(20)30514-X/abstract">Alzheimer’s disease</a>, HIV-associated neurodegeneration, and <a href="https://www.sciencedirect.com/science/article/abs/pii/S0376871623005549?via%3Dihub">methamphetamine addiction</a>. The platform halted neurodegenerative progression and restored learning and memory, and delivered robust neuronal protection in each disorder. These findings were presented by ExQor at leading medical conferences and published in<a href="https://www.nature.com/articles/s42003-022-03177-3"> Nature Communications Biology</a>. </p> <p>Together, these results underscore the broad potential of ExQor’s platform as a treatment for diverse neurodegenerative and neuropsychiatric disorders or possibly prevention.</p> <p> </p> </div> <div class="col-lg-12 col-md-6 col-sm-12 text-align"> <h4><strong> <center> <p>Breakthrough Brain Delivery Technology </p> <p><span class="text-center"><img src="images/BBB_IMAGE.jpg" alt="" width="285" height="222" align="center"/></span></p> </center> </strong></h4> <p><BR> The primary challenge in treating neurodegenerative diseases has been delivering therapeutic agents across the blood-brain barrier, which protects the brain but prevents 99% of potential treatments from reaching their targets. </p> <p>ExQor's innovative delivery platform overcomes this obstacle, achieving therapeutic biologic concentrations in the brain <strong>up to <a href="images/NIH_WORKSHOP_EXQOR_PFound 2026-01-12 by HttpPluginCreate report